In lieu of a fast IPO bounce again, life sciences legal professionals anticipate various financings and combos to choose up in 2023, together with continued momentum for regulatory experience.
Legal professionals who attended the JP Morgan Healthcare Convention in San Francisco earlier this month stated the overall temper of life sciences stakeholders ranged from “guardedly impartial” to “settled.”